Life Technologies Launches 3500 Dx Series Genetic Analyzer in Asia Pacific

24 August 201

The 3500 Dx Series Genetic Analyzers are intended for use in the analysis of human DNA or RNA for the detection of genetic changes that may lead to disease presence or susceptibility. The 3500 Series enables researchers to run up to 1,100 sequencing or 1,200 genotyping samples per day. It features a novel consumables design that incorporates the ability to track key information with radio frequency identification (RFID) tags, new optical and thermal sub-systems, and redesigned data collection and analysis software, creating a more cost-effective method for high-quality data analyses.

"We are very excited to see the 3500 Dx Genetic Analyzer be accepted and approved for sale across the Asia Pacific Region," said Mark Smedley, head of the Asia Pacific region for Life Technologies. "Life Technologies is proud to be working with these nations, providing them with enabling genetic sequencing systems and is committed to advancing human health and combating critical human diseases like cancer."

The 3500 Dx Series Genetic Analyzers are part of a broader portfolio of advanced genomic technologies that are built upon Applied Biosystems' legacy of providing platforms that are recognized for proven technology, reliability and performance. They provide an integrated solution that combines the instrument with Applied Biosystems reagents, consumables, software, and world class service and support.

The 3500 Dx platform is also available in the following European countries: Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, Luxembourg, the Netherlands, Norway, Poland, Spain, Sweden, Switzerland, and the United Kingdom.